You have 8 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Anti-tumor necrosis factor alpha monoclonal antibody

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Breast Cancer, Colon Cancer, Extrahepatic Bile Duct Cancer Trial in Duarte (procedure, other, drug)

Active, not recruiting
  • Breast Cancer
  • +11 more
  • radionuclide imaging
  • +4 more
  • Duarte, California
    City of Hope Medical Center
Oct 20, 2022

Adult Solid Tumor Trial (HLX26, HLX10)

Recruiting
  • Adult Solid Tumor
  • Xuzhou, Jiangsu, China
    Xuzhou Central Hospital
Oct 17, 2022

Solid Tumor and Lymphoma Trial (HLX60)

Not yet recruiting
  • Solid Tumor and Lymphoma
  • (no location specified)
Nov 1, 2022

Recurrent Osteosarcoma Trial in Los Angeles, New York, Houston (humanized anti-GD2 antibody, GM-CSF)

Recruiting
  • Recurrent Osteosarcoma
  • humanized anti-GD2 antibody
  • GM-CSF
  • Los Angeles, California
  • +2 more
Dec 22, 2022

Estrogen Receptor Negative, Estrogen Receptor Positive, HER2/Neu Negative Trial in Bellevue, Grand Island, Omaha (drug, other,

Active, not recruiting
  • Estrogen Receptor Negative
  • +15 more
  • Bellevue, Nebraska
  • +3 more
Nov 30, 2022

Platinum-Resistant Fallopian Tube Carcinoma, Platinum-Resistant Ovarian Carcinoma, Platinum-Resistant Primary Peritoneal

Completed
Has Results
  • Platinum-Resistant Fallopian Tube Carcinoma
  • +8 more
  • Bevacizumab
  • Irinotecan Sucrosofate
  • Chicago, Illinois
    Northwestern University
Dec 21, 2022

Platinum-refractory Ovarian Carcinoma, Platinum-resistant Ovarian Cancer Trial in Rochester, Helsinki (TILT-123, Pembrolizumab)

Recruiting
  • Platinum-refractory Ovarian Carcinoma
  • Platinum-resistant Ovarian Cancer
  • TILT-123
  • Pembrolizumab
  • Rochester, Minnesota
  • +1 more
Aug 12, 2022

Resectable Hepatocellular Carcinoma, Stage I Hepatocellular Carcinoma AJCC v8, Stage IA Hepatocellular Carcinoma AJCC v8 Trial

Recruiting
  • Resectable Hepatocellular Carcinoma
  • +4 more
  • Atezolizumab
  • +2 more
  • Houston, Texas
  • +1 more
Oct 12, 2022

Recurrent Brain Tumor Trial in Houston (biological, other, radiation)

Active, not recruiting
  • Recurrent Brain Neoplasm
  • Bevacizumab
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Dec 9, 2022

Lung Cancer Trial (TILT-123, Pembrolizumab)

Not yet recruiting
  • Lung Cancer
  • TILT-123
  • Pembrolizumab
  • (no location specified)
Nov 5, 2023

Crohn Disease Trial in Evansville (JNJ-64304500, Placebo, Adalimumab)

Withdrawn
  • Crohn Disease
  • Evansville, Indiana
    Medisphere Medical Research Center, Llc
Aug 30, 2021

Stage IA Non-Small Cell Lung Carcinoma, Stage IB Non-Small Cell Lung Carcinoma Trial in Palo Alto (biological, other, radiation)

Completed
  • Stage IA Non-Small Cell Lung Carcinoma
  • Stage IB Non-Small Cell Lung Carcinoma
  • Fresolimumab
  • +2 more
  • Palo Alto, California
    Stanford University, School of Medicine
Feb 2, 2022

Advanced Solid Tumor Trial in Zhengzhou, Linyi (BAT4706 Injection, BAT1308 Injection)

Not yet recruiting
  • Advanced Solid Tumor
  • BAT4706 Injection
  • BAT1308 Injection
  • Zhengzhou, Henan, China
  • +2 more
Nov 14, 2023

Solid Tumor, Adult Trial in Australia, Hong Kong (CS1002, CS1003)

Completed
  • Solid Tumor, Adult
  • Albury, New South Wales, Australia
  • +9 more
Dec 15, 2022

Healthy Trial (human recombinant anti-tumor necrosis factor alpha mAb injection, adalimumab)

Completed
  • Healthy
  • human recombinant anti-tumor necrosis factor alpha monoclonal antibody injection
  • adalimumab
  • (no location specified)
Mar 6, 2019

Metastatic Colorectal Carcinoma, Metastatic Malignant Tumor in the Liver, Stage IV Colorectal Cancer AJCC v8 Trial (biological,

Not yet recruiting
  • Metastatic Colorectal Carcinoma
  • +3 more
  • Bevacizumab
  • +11 more
  • (no location specified)
May 9, 2023

Solid Tumor Trial in Shanghai (HLX07)

Not yet recruiting
  • Solid Tumor
  • Shanghai, China
    Fudan University shanghai cancer center
May 3, 2022

Diabetes, Type 1 Trial (Golimumab, Placebo)

Withdrawn
  • Diabetes Mellitus, Type 1
  • (no location specified)
Nov 19, 2021

Recurrent Fallopian Tube Carcinoma, Recurrent Ovarian Carcinoma, Recurrent Primary Peritoneal Carcinoma Trial in Phoenix,

Recruiting
  • Recurrent Fallopian Tube Carcinoma
  • +2 more
  • Bevacizumab
  • +4 more
  • Phoenix, Arizona
  • +2 more
Jun 27, 2022

Metastatic Colorectal Cancer, Non Small Cell Lung Cancer Metastatic, Non Small Cell Lung Cancer Recurrent Trial in Hefei

Completed
  • Metastatic Colorectal Cancer
  • +2 more
  • Hefei, Anhui, China
    The Second Hospital of Anhui Medical University
Oct 27, 2021

Rheumatoid Arthritis Trial in Canada, United States (ISIS 104838)

Completed
  • Rheumatoid Arthritis
  • ISIS 104838
  • Birmingham, Alabama
  • +30 more
Dec 1, 2022

Advanced Solid Tumor Trial (STI-7349, Pembrolizumab)

Not yet recruiting
  • Advanced Solid Tumor
  • (no location specified)
Aug 3, 2023

Locally Advanced/Metastatic Solid Tumors Trial in Shanghai (PE0116)

Active, not recruiting
  • Locally Advanced/Metastatic Solid Tumors
  • Shanghai, China
    复旦大学附属中山医院
Mar 23, 2023

Recurrent Colorectal Carcinoma, Stage IVA Colorectal Cancer, Stage IVB Colorectal Cancer Trial in Buffalo, Cleveland (Cetuximab,

Completed
Has Results
  • Recurrent Colorectal Carcinoma
  • +2 more
  • Cetuximab
  • +2 more
  • Buffalo, New York
  • +1 more
Sep 29, 2022

Aneurysm, Stroke, Vasculitis Trial in San Francisco (Infliximab)

Enrolling by invitation
  • Aneurysm
  • +3 more
  • San Francisco, California
    UCSF Medical Center
Apr 25, 2022